Yatan Pal Singh Balhara1, Raka Jain. 1. Department of Psychiatry and De-Addiction, Lady Hardinge Medical College and SSK Hospital, New Delhi, India.
Abstract
OBJECTIVE: In view of increasing safety concerns, there is a need to assess benefits of use of dextropropoxyphene as opioid substitution treatment, if any. This study aims at urinalysis-based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects. SETTING: Laboratory of a tertiary care drug-dependence treatment center. PARTICIPANTS: Patients on buprenorphine and dextropropoxyphene therapy and their urinalysis records. INTERVENTIONS: Nonexperimental chart review method. MAIN OUTCOME MEASURE(S): "Use," "abuse, "and 'prescribed but not used rates" for buprenorphine and dextropropoxyphene were compared, using chi2-test with level of significance at p < 0.05. RESULTS: Rate of "use" and "abuse" was significantly high for dextropropoxyphene. Rate of 'prescribed but not used" was significantly high for buprenorphine (p < 0.05). CONCLUSIONS: Despite apparent benefits of dextropropoxyphene use in terms of better rates of "use" and 'prescribed but not used" as compared to buprenorphine, one needs to review the situation in light of recent reports of adverse effects with dextropropoxyphene and limited resources available.
OBJECTIVE: In view of increasing safety concerns, there is a need to assess benefits of use of dextropropoxyphene as opioid substitution treatment, if any. This study aims at urinalysis-based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects. SETTING: Laboratory of a tertiary care drug-dependence treatment center. PARTICIPANTS: Patients on buprenorphine and dextropropoxyphene therapy and their urinalysis records. INTERVENTIONS: Nonexperimental chart review method. MAIN OUTCOME MEASURE(S): "Use," "abuse, "and 'prescribed but not used rates" for buprenorphine and dextropropoxyphene were compared, using chi2-test with level of significance at p < 0.05. RESULTS: Rate of "use" and "abuse" was significantly high for dextropropoxyphene. Rate of 'prescribed but not used" was significantly high for buprenorphine (p < 0.05). CONCLUSIONS: Despite apparent benefits of dextropropoxyphene use in terms of better rates of "use" and 'prescribed but not used" as compared to buprenorphine, one needs to review the situation in light of recent reports of adverse effects with dextropropoxyphene and limited resources available.
Authors: Kenneth Blum; Marlene Oscar-Berman; John Femino; Roger L Waite; Lisa Benya; John Giordano; Joan Borsten; William B Downs; Eric R Braverman; Raquel Loehmann; Kristina Dushaj; David Han; Thomas Simpatico; Mary Hauser; Debmalya Barh; Thomas McLaughlin Journal: J Addict Res Ther Date: 2013-04-23